A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia

• Status: Completed
• Trial end date: 2016-03-10
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether EV06 Ophthalmic Solution is safe and effective in improving distance corrected near vision in people who have presbyopia.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Encore Vision, Inc.
• Treatments: Choline; Ophthalmic Solutions; Pharmaceutical Solutions; Thioctic Acid

Criteria

Inclusion Criteria:

• 45 to 55 years of age

• Distance Corrected Near Visual Acuity worse than 20/40

• Best Corrected Distance Visual Acuity of 20/20 or better in each eye

• Willing and able to sign consent, following study instructions

Exclusion Criteria:

• Certain pupillary conditions

• Significant astigmatism, glaucoma, diabetes, cataracts, eye surgery, ocular trauma or accommodative issues

• contact lens wear within 3 days prior to and for duration of study

• use of prohibited medications

• participation in a clinical study within 30 days prior